- Capreomycin
-
Capreomycin Systematic (IUPAC) name (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide; (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide Clinical data AHFS/Drugs.com monograph MedlinePlus a682860 Pregnancy cat. ? Legal status ? Identifiers CAS number 11003-38-6 ATC code J04AB30 PubChem CID 3032400 DrugBank APRD00844 ChemSpider 21106276 UNII 232HYX66HC KEGG D00135 ChEMBL CHEMBL1201252 Chemical data Formula C25H44N14O8 Mol. mass 668.706 g/mol - InChI=1S/C25H44N14O8.C25H44N14O7/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46)/b15-9-;16-10-/t11-,12?,13?,14+,16+,18?;11-,12+,13?,14?,15-,18?/m10/s1
Key:VCOPTHOUUNAYKQ-TWKMCICTSA-N
(what is this?) (verify) Capreomycin is a peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for tuberculosis. Adverse effects include nephrotoxicity and 8th cranial nerve toxicity.
The drug should not be given with streptomycin or other drugs that may damage the 8th nerve.
It is a cyclic peptide. Capreomycin is administered intramuscularly and shows bacteriostatic activity. [1]
References
Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04) Nucleic acid inhibitor Antifolates/DSIASAProtein synthesis inhibitor Cell envelope antibiotic Peptidoglycan layerArabinogalactan layerEthylenediamine/arabinosyltransferase inhibitor: Ethambutol#
SQ109†Mycolic acid layerHydrazides/mycolic acid synth. inhibition: Isoniazid#
Thiocarbamides: Ethionamide# • Prothionamide • ThiocarlideOther/unknown phenazine (Clofazimine)# • pyrazine (Pyrazinamide#, Morinamide) • isoxazole (Terizidone) • R207910/TMC207†Combinations Rifampicin/isoniazid/pyrazinamideThis antiinfective drug article is a stub. You can help Wikipedia by expanding it. - InChI=1S/C25H44N14O8.C25H44N14O7/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46)/b15-9-;16-10-/t11-,12?,13?,14+,16+,18?;11-,12+,13?,14?,15-,18?/m10/s1